Safety Study of Non-invasive Ventilation Versus High-flow Oxygen in Patients With Hypoxemic Respiratory Failure Undergoing Fiberoptic Bronchoscopy.
Prospective Randomised Study on the Safety of Non-invasive Ventilation Versus High-flow Oxygen in Patients With Hypoxemic Respiratory Failure Undergoing Fiberoptic Bronchoscopy.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Hamburg, Germany, 20246
- Universitätsklinikum Hamburg-Eppendorf, Department of Intensive Care Medicine
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients treated in an intensive care unit
- indication for bronchoscopy and broncho-alveolar lavage
- presence of hypoxemic (SaO2/fraction of inspired oxygen(FiO2): 300 or less) and/or hypercapnic respiratory failure
Exclusion Criteria:
- patients already on invasive ventilation
- indication for intubation
- blocked nasopharynx
- contraindications for non-invasive ventilation or high-flow oxygen
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: non-invasive ventilation
Performance of bronchoscopy during non-invasive ventilation.
|
non-invasive ventilation via face mask
fiberoptic bronchoscopy including broncho-alveolar lavage
|
|
Experimental: high-flow oxygen
Performance of bronchoscopy during high-flow oxygen therapy.
|
fiberoptic bronchoscopy including broncho-alveolar lavage
high-flow oxygen via nasal cannula
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mean decrease in the saturation of oxygen (SpO2) during bronchoscopy.
Time Frame: during fiberoptic bronchoscopy
|
during fiberoptic bronchoscopy
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Changes in blood gases after the completion of fiberoptic bronchoscopy.
Time Frame: 1 hour after the completion of bronchoscopy
|
1 hour after the completion of bronchoscopy
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Requirement of intubation after the completion of bronchoscopy.
Time Frame: 8 hours after the completion of bronchoscopy
|
8 hours after the completion of bronchoscopy
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- PV-4442
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.